![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, August 12, 2015 8:51:01 PM
https://www.crunchbase.com/person/krishna-menon
Dr. Menon was originally trained as a veterinary surgeon. He was Director of Agriculture for Cayman Islands, in the British Caribbean during 1978-1981. Thereafter he came to the Dana Farber Cancer Research Institute and obtained a PhD in Pharmacology in 1984 from Harvard University. He worked under the direction of Nobel Laureate Dr. Tom Frye. His PhD work involved anti-folate therapy of various cancers, which has led to the extremely important drugs, methotrexate and recently, the blockbuster Alimta. He was Research Scientist at Dana Farber between 1985 to 1990. He was Senior Research Scientist, In Vivo Research (Cancer), at Bayer Pharmaceuticals (Miles Laboratories) during 1991-1993. He had his own veterinary oncology and drug development consultancy practice during 1994. Thereafter, he was Group Leader, Cancer In Vivo Research and Clinical Development, at Eli Lilly and Company during 1995-2001. He was responsible for the development of the anticancer drugs Cryptophycin and the blockbusters, Gemzar and Alimta. He also helped developed another seven compounds at Lilly which are in late clinical phases at present. He has also contributed to the development of an anti-infective drug by Nexus Pharmaceuticals.
Dr. Menon won the Employee of the Year, President's Award at Eli Lilly for 1999. Later, he was the Director of Operations for the ALS Therapy Development Foundation during 2001-2002 (ALS is acute lateral sclerosis, a disease related to Lou Gehrig's Syndrome). He is a Founder and Board Member of KARD Scientific, Cambridge, MA; KARD Inc., Wilmington, MA; as well as KARD Scientific India, Bangalore, India and KARD Medics, Mumbai, India. He is a Director of Biological Supplies, New York, NY. He is a Member of the Scientific Advisory Board of Nexus Pharmaceuticals, Philadelphia, PA and TheraCour Pharma, Inc., West Haven, CT. He is Distinguished Scientist and Scientific Diplomat for GPC-Biotech, Germany. Dr. Menon is a Certified Toxicologist and a Member of the American Association of Toxicology. He holds a VMD from Triniti University, Peru, and MRCS from Royal University of Copenhagen. He is a practicing veterinary surgeon and human physician, licensed in various countries.
Dr. Menon participated in the development of 8 International and 3 US patents, including the one for Alimta. He has been responsible for 7 FDA approved drugs, 3 of which are blockbusters. While at Harvard, he conducted pre-clinical studies on the important anti-HIV drug, AZT. He is well known for his grasp of scientific and regulatory matters in taking a compound from the Chemist's bench to FDA approval. He is regularly invited to lecture across the globe on the drug development process and the regulatory landscape.
- See more at: https://www.crunchbase.com/person/krishna-menon#sthash.P8ZZMxUC.dpuf
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM